Prior presentation: These data have not previously been presented.
Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual†
Version of Record online: 12 FEB 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 22, Issue 5, pages 488–495, May 2013
How to Cite
Avery, T. R., Kulldorff, M., Vilk, Y., Li, L., Craig Cheetham, T., Dublin, S., Davis, R. L., Liu, L., Herrinton, L. and Brown, J. S. (2013), Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidem. Drug Safe., 22: 488–495. doi: 10.1002/pds.3412
- Issue online: 3 MAY 2013
- Version of Record online: 12 FEB 2013
- Manuscript Accepted: 2 JAN 2013
- Manuscript Revised: 28 NOV 2012
- Manuscript Received: 29 AUG 2012
Additional supporting information may be found in the online version of this article:
|pds3412_sm_appendecis.xlsx||Excel 2007 spreadsheet||945K||SUPPORTING INFORMATION|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.